Cargando…
Selective Serotonin Reuptake Inhibitor-Treatment Does Not Show Beneficial Effects on Cognition or Amyloid Burden in Cognitively Impaired and Cognitively Normal Subjects
Preclinical studies indicate that selective serotonin reuptake inhibitors (SSRI) have beneficial effects on Alzheimer-related pathologies. Therefore, the aim of this study was to evaluate the influence of SSRI-treatment on amyloid burden in (18)F-Florbetapir-positron emission tomography (PET) and on...
Autores principales: | Bouter, Yvonne, Bouter, Caroline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260503/ https://www.ncbi.nlm.nih.gov/pubmed/35813957 http://dx.doi.org/10.3389/fnagi.2022.883256 |
Ejemplares similares
-
Serotonin reuptake inhibitors and its cognitive burden…or relief.: A brief review
por: Amorim, M. J., et al.
Publicado: (2023) -
Cerebral blood flow, amyloid burden, and cognition in cognitively normal individuals
por: Ebenau, Jarith L., et al.
Publicado: (2022) -
Does amyloid deposition produce a specific atrophic signature in cognitively normal subjects?()
por: Whitwell, Jennifer L., et al.
Publicado: (2013) -
Altered metamemory precedes cognitive impairment in subjective cognitive decline with positive amyloid-beta
por: Li, QinJie, et al.
Publicado: (2022) -
Selective serotonin reuptake inhibitors and inflammatory bowel disease; Beneficial or malpractice
por: Hatamnejad, Mohammad Reza, et al.
Publicado: (2022)